Navigation Links
Berkery Noyes Represented The Riverside Company on the Sale of HCPro Holdings, Inc. to Halyard Capital, LLC
Date:2/13/2008

NEW YORK, Feb. 13 /PRNewswire/ -- Berkery Noyes announced today that the firm represented The Riverside Company on the sale of its portfolio company HCPro Holdings, Inc. to Halyard Capital. The management team will continue to have an investment in the new entity. Terms of the transaction were not disclosed.

"This is an excellent match with Halyard Capital backing a veteran management team with a winning healthcare and information franchise," said Tom O'Connor, the Berkery Noyes Managing Director who managed the transaction on behalf of Riverside Company. "HCPro is a world class franchise in a growth segment of the ever expanding healthcare market," O'Connor added.

Berkery Noyes has been involved with many of the most notable transactions in the healthcare, pharmaceutical tools and services, and medical marketing sectors involving both strategic and financial buyers and sellers.

Berkery Noyes acted as The Riverside Company's exclusive financial advisor and represented it in its negotiations with Halyard Capital, LLC.

About Berkery Noyes

Berkery Noyes is one of the pre-eminent merger and acquisition firms serving the information industry, having completed more than 400 transactions since its inception. Among the most recent transactions completed by Berkery Noyes are the sale of Center Watch/NEIRB to Jobson Medical Information a portfolio company of The Wicks Group, HMP Communications to Alta Communications in partnership with Paul Mackler and Ken Fisher, the sale of Complete Healthcare Communications to MediMedia a portfolio company of Vestar Capital Partners, the divesture by The Thomson Corporation of American Health Consultants to Thompson Publishing Group; acquisition by Springer Science + Business Media of Current Medicine Group; acquisition by WebMd Corporation of Conceptis and the acquisition by The Wicks Group of DesignWrite, Inc..

Berkery Noyes' clients include private companies seeking a buyer, most of the major international information companies, and private equity firms who use the firm's expertise in locating, analyzing and negotiating with acquisition candidates and in managing divestitures. The firm operates with a staff of forty professionals serving the information and publishing industry. For more information, visit http://www.berkerynoyes.com.

About HCPro Holdings

HCPro Holdings, Inc. is the largest provider of information, educational, and advisory products and services in the vital areas of compliance, regulation, and management to the U.S. Healthcare Industry. The company delivers its "need-to-know" content in a wide variety of complementary, integrated formats, including print and electronic newsletters, e-mail services, magazines, books, online products, software, broadcast events, seminars, conferences, classroom training, consulting, membership programs and videos to meet the specialized needs of healthcare managers. The Company's leading brands, HCPro, HealthLeaders Media, and The Greeley Company, are well-known and highly respected by healthcare managers. http://www.hcpro.com

About The Riverside Company

The Riverside Company is the largest global private equity firm focused on the smaller end of the middle market ("SEMM") and is one of the industry's most experienced leveraged buyout investors. Riverside specializes in investing in premier SEMM companies (those with enterprise values of less than $150 million) and partners with strong management teams to build companies through acquisitions and value-added growth. Riverside offers the resources to complete acquisitions smoothly and in as little as 30 days -- thanks to its sizeable pool of capital under management (nearly $2 billion in nine funds), over 150 professionals in 17 offices (Amsterdam, Atlanta, Budapest, Brussels, Chicago, Cleveland, Dallas, Los Angeles, Madrid, Munich, New York, Prague, San Francisco, Seoul, Stockholm, Tokyo and Warsaw), and long-standing relationships with partner lenders. Please visit http://www.riversidecompany.com


'/>"/>
SOURCE Berkery Noyes
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pulmonary Fibrosis Patients/9/11 Responders Represented at State of the Union Address for Second Year in a Row
2. Riverside First to Offer New Treatment for Peripheral Arterial Disease
3. Riverside Partners Teams with Management to Acquire GEMCITY Engineering & Manufacturing
4. Cogdell Spencer Announces a $100 Million Development at St. Lukes Riverside Outpatient Campus In Bethlehem, Pennsylvania
5. Susan G. Komen for the Cure, U.S. Congressman Pat Tiberi, Ohio Senator Tom Niehaus, and OhioHealth Riverside Breast Health Center Call for Action on Breast Cancer
6. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
7. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
8. Cleveland-based Health Care Tech Company Within3 Names New CEO
9. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
10. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
11. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology: